Details of the Drug

General Information of Drug (ID: DMJVGIH)

Drug Name

AIGIV

Synonyms

Anthrax immune globulin therapy (intravenous); Anthrax immune globulin therapy (intravenous), Emergent

Indication

Disease Entry	ICD 11	Status	REF
Diabetic neuropathy	8C0Z	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bacillus anthracis Protective antigen (Anthrax PA)	TTRLPUB	PAG_BACAN	Modulator	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT00845650) Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV). U.S. National Institutes of Health.
2	Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92.